國立虎尾科技大學 |

Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology/ edited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió.
other author:	Fanti, Stefano.
Description:	XIII, 488 p. 340 illus., 316 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Nuclear medicine. -
Online resource:	https://doi.org/10.1007/978-3-030-68858-5
ISBN:	9783030688585

Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology
Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology[electronic resource] /edited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió. - 1st ed. 2021. - XIII, 488 p. 340 illus., 316 illus. in color.online resource.

PART I General Chapters: Introduction to Treatment response evaluation: Science and Practice -- CT in Treatment response evaluation – Overview -- MRI & Diffusion weighted MRI in Treatment response evaluation- Overview -- PET & PET-CT in Treatment response evaluation-Overview -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in post-surgical setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in chemotherapy setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in radiation oncology -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in Immunotherapy settings -- Treatment response evaluation of bone metastases using 18F-NaF -- How to report PET-CT scans in post therapy scenarios: Do’s and don’ts -- PART II Atlas Articles: 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Head and neck cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in lung cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in neuro-oncology -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in hepatobiliary cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gastroesophageal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Lymphoma and Non-hodgkins lymphoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in breast cancer -- 18F-FDG, 18F-Choline & 68Ga-PSMA PET-CT in Treatment response evaluation in prostate cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gynaecological cancers -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in colorectal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in soft tissue sarcomas -- FDG & Non FDG PET-CT in Treatment response evaluation in malignant melanoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in myeloma -- FDG PET-CT & 18F-NaF in Treatment response evaluation in bone metastases and bone tumours -- 18F-FDG & Non FDG PET-CT in Assessment of treatment response in paediatric oncology -- 68Ga-DOTA PET-CT in Treatment response evaluation in NETs -- 18F-DOPA PET-CT in Treatment response evaluation -- 18F-FLT PET-CT in Treatment response evaluation -- Brain PET-CT in Treatment response evaluation.

This text atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.

ISBN: 9783030688585

Standard No.: 10.1007/978-3-030-68858-5doiSubjects--Topical Terms:

673902
Nuclear medicine.

LC Class. No.: R895-920

Dewey Class. No.: 616.07548

Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology
LDR:04907nam a22003855i 4500 001 1046976
003 DE-He213
005 20210921172532.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030688585 $9 978-3-030-68858-5
024 7 $a 10.1007/978-3-030-68858-5 $2 doi
035 $a 978-3-030-68858-5
050 4 $a R895-920
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
072 7 $a MKR $2 thema
082 0 4 $a 616.07548 $2 23
245 1 0 $a Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology $h [electronic resource] / $c edited by Stefano Fanti, Gopinath Gnanasegaran, Ignasi Carrió.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XIII, 488 p. 340 illus., 316 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a PART I General Chapters: Introduction to Treatment response evaluation: Science and Practice -- CT in Treatment response evaluation – Overview -- MRI & Diffusion weighted MRI in Treatment response evaluation- Overview -- PET & PET-CT in Treatment response evaluation-Overview -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in post-surgical setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in chemotherapy setting -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in radiation oncology -- Conventional Radiological Techniques and PET-CT in Treatment response evaluation in Immunotherapy settings -- Treatment response evaluation of bone metastases using 18F-NaF -- How to report PET-CT scans in post therapy scenarios: Do’s and don’ts -- PART II Atlas Articles: 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Head and neck cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in lung cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in neuro-oncology -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in hepatobiliary cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gastroesophageal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in Lymphoma and Non-hodgkins lymphoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in breast cancer -- 18F-FDG, 18F-Choline & 68Ga-PSMA PET-CT in Treatment response evaluation in prostate cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in gynaecological cancers -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in colorectal cancer -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in soft tissue sarcomas -- FDG & Non FDG PET-CT in Treatment response evaluation in malignant melanoma -- 18F-FDG & Non FDG PET-CT in Treatment response evaluation in myeloma -- FDG PET-CT & 18F-NaF in Treatment response evaluation in bone metastases and bone tumours -- 18F-FDG & Non FDG PET-CT in Assessment of treatment response in paediatric oncology -- 68Ga-DOTA PET-CT in Treatment response evaluation in NETs -- 18F-DOPA PET-CT in Treatment response evaluation -- 18F-FLT PET-CT in Treatment response evaluation -- Brain PET-CT in Treatment response evaluation.
520 $a This text atlas is a superb guide to the use of PET-CT for the evaluation of treatment response in oncology patients based on its ability to assess tumor metabolic status. The first part of the book explains the role of PET-CT in response evaluation in different treatment settings. For comparison, overviews of the value and limitations of CT alone, PET alone, and anatomical and functional MRI are included. Guidance is also provided on the reporting of PET-CT scans in post-therapy scenarios. The second part of the book describes and illustrates the use of PET-CT with FDG and other tracers to assess the treatment response of malignancies at different anatomic sites. Featuring a wealth of images, informative case-based discussion, and evidence-based teaching points, these disease-specific chapters clearly demonstrate the key role that PET-CT can play in distinguishing early responders from patients who are non-responders or are resistant to treatment. Prompt and accurate evaluation of treatment response is vital as we enter the era of individualized medicine, and this atlas will persuade readers of the considerable advantages of PET-CT over conventional radiological and clinical methods.
650 0 $a Nuclear medicine. $3 673902
650 0 $a Oncology . $3 1253469
650 1 4 $a Nuclear Medicine. $3 673045
650 2 4 $a Oncology. $3 593951
700 1 $a Fanti, Stefano. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 796628
700 1 $a Gnanasegaran, Gopinath. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 881724
700 1 $a Carrió, Ignasi. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298038
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030688578
776 0 8 $i Printed edition: $z 9783030688592
856 4 0 $u https://doi.org/10.1007/978-3-030-68858-5
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)